Sagimet Biosciences Inc.
SGMT
$2.21
$0.199.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.38% | 49.73% | 798.92% | 667.03% | 193.39% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.52% | 379.04% | 143.14% | 79.37% | 227.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.62% | 428.57% | -95.26% | -92.37% | 1,067.65% |
| Total Current Assets | 58.08% | 52.88% | 680.89% | 619.06% | 194.72% |
|
|
|||||
| Total Current Assets | 58.08% | 52.88% | 680.89% | 619.06% | 194.72% |
| Net Property, Plant & Equipment | 5.48% | 4.59% | 4.86% | -79.21% | -65.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 65.70% | 69.81% | 779.24% | 613.79% | 192.81% |
|
|
|||||
| Total Accounts Payable | 666.13% | -32.31% | -26.77% | -63.66% | -83.47% |
| Total Accrued Expenses | -39.22% | -10.67% | 77.40% | 48.83% | 22.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.00% | 12.62% | 9.29% | -81.02% | -51.13% |
| Total Finance Division Other Current Liabilities | -99.10% | -88.42% | -97.57% | -- | 875.44% |
| Total Other Current Liabilities | -99.10% | -88.42% | -97.57% | -- | 875.44% |
| Total Current Liabilities | -21.22% | -18.95% | 8.34% | -14.70% | 7.10% |
|
|
|||||
| Total Current Liabilities | -21.22% | -18.95% | 8.34% | -14.70% | 7.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.22% | -18.97% | 8.34% | -15.32% | 5.47% |
|
|
|||||
| Common Stock & APIC | 32.31% | 32.37% | 1,116.00% | 1,147.96% | 873.60% |
| Retained Earnings | -18.25% | -15.53% | -12.43% | -12.22% | -12.56% |
| Treasury Stock & Other | 666.67% | -- | -- | 153.85% | 135.71% |
| Total Common Equity | 71.09% | 74.39% | 192.38% | 198.61% | 148.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.09% | 74.39% | 192.38% | 198.61% | 148.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.09% | 74.39% | 1,030.66% | 766.59% | 229.11% |
|
|
|||||